CTNNB1 and adrenal cortex carcinoma: A number of target genes for activated beta-catenin has been described in the H295R ACC cell line (where beta-catenin is constitutively activated due to a CTNNB1 mutation) after selective downregulation of beta catenin by expression of an inducible shRNA (16).